Impact of Daily Stair Climbing on Cardiopulmonary Rehabilitation in Heart Patients
ConditionRehabilitation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre Hospitalier Arras
About this trial
The goal of this interventional study is to improve exercise capacity of patients following a standard rehabilitation program in Arras Hospital with stair climbing .
Patients will be randomized in to 2 groups : intervention or control.
* Control group will follow standard program. * Intervention group will follow standard program and stair climbing (2 floors, twice a day until the exit).
Patients will complete questionnaires and tests before starting study and again at the end (approximately 10 days).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥18 years
Patients requiring cardiac rehabilitation admitted to the Eole unit
Patients ability to walk at least 200 meters without technical assistance
Disqualifiers
Patient walking with an assistive device
Patient with a contraindication to climbing stairs
Pre-operative patient
Patient with a pacemaker
Trial design
Design model
Parallel
Treatments tested in this trial
stair climb
Other intervention2 times a day, until exit service (excluding weekends), they will climb two floors of stairs (morning and afternoon, supervised by a therapist)
Treatment groups
90 Participants
are divided into 2 treatment groupsGroup A: Standard program of rehabilitationNo intervention 0 interventions
Group B: standard program of rehabilitation + stair climbExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Evolution of number of repetitions on chair stand test
Evolution of number of repetitions in 1 minute on chair stand test between entry and exit of study
Time frame
at 10 days or at time of study exit if the patient leaves earlierSecondary outcomes
1
Evolution of dyspnea
Evolution of dyspnea (with Modified Medical Research Council (mMRC) scale) between entry and exit of study. The scale is from 0 to 4. The higher the stage, the more severe the dyspnea.
Time frame
at 10 days or at time of study exit if the patient leaves earlier2
Evolution of distance covered on 6-minute walk test
Evolution of distance covered on 6-minute walk test between entry and exit of study.
Time frame
at 10 days or at time of study exit if the patient leaves earlier3
Evolution of quality life score
Evolution of quality life score with the World Health Organization Quality of Life Bref (WHOQOL Bref) questionnaire between entry and exit study. Measures overall quality of life in four domains: physical, psychological, social relationships, and environment.
Time frame
at 10 days or at time of study exit if the patient leaves earlier4
Evolution of muscle mass of lower limb
Evolution of muscle mass in lower limb muscle mass measured by bioelectrical impedance between entry and exit of study
Time frame
at 10 days or at time of study exit if the patient leaves earlierSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov